J
Jessica P. Hwang
Researcher at University of Texas MD Anderson Cancer Center
Publications - 74
Citations - 5997
Jessica P. Hwang is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Hepatitis B virus. The author has an hindex of 22, co-authored 64 publications receiving 4372 citations. Previous affiliations of Jessica P. Hwang include University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault,Anna S. Lok,Brian J. McMahon,Kyong-Mi Chang,Jessica P. Hwang,Maureen M. Jonas,Robert S. Brown,Natalie Bzowej,John B. Wong +8 more
TL;DR: This AASLD 2018 Hepatitis B Guidance provides a data-supported approach to screening, prevention, diagnosis, and clinical management of patients with hepatitis B.
Journal ArticleDOI
AASLD guidelines for treatment of chronic hepatitis B
Norah A. Terrault,Natalie Bzowej,Kyong-Mi Chang,Jessica P. Hwang,Maureen M. Jonas,M. Hassan Murad +5 more
TL;DR: Aasld Guidelines for Treatment of Chronic Hepatitis B Norah Terrault;Natalie Bzowej;Kyong-Mi Chang;Jessica Hwang;Maureen Jonas;Hassan Murad; Hepatology
Journal ArticleDOI
Management of patients with hepatitis B who require immunosuppressive therapy
Jessica P. Hwang,Anna S.F. Lok +1 more
TL;DR: The incidence, risk factors and outcomes of HBV reactivation, and the efficacy of antiviral therapy in preventing its occurrence are reviewed and an algorithm for managing patients with HBV infection who require immunosuppressive therapy is proposed.
Journal ArticleDOI
Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update
Jessica P. Hwang,Mark R. Somerfield,Devena E. Alston-Johnson,Donna R. Cryer,Jordan J. Feld,Barnett S. Kramer,Anita L. Sabichi,Sandra L. Wong,Andrew S. Artz +8 more
TL;DR: A risk-adaptive strategy to identify and treat patients with HBV infection to reduce their risk of HBV reactivation is introduced, based on American Society of Clinical Oncology panel consensus in the context of an evolving database.
Journal ArticleDOI
Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma.
Lung-Yi Mak,Vania Cruz-Ramón,Paulina Chinchilla-López,Harrys A. Torres,Noelle K. LoConte,John P. Rice,Lewis E. Foxhall,Erich M. Sturgis,Janette K. Merrill,Howard H. Bailey,Nahum Méndez-Sánchez,Man Fung Yuen,Jessica P. Hwang +12 more
TL;DR: For management of HCC, early diagnosis via imaging surveillance among persons with HCC risk factors remains the most important strategy to identify early-stage disease appropriate for resection or transplantation.